アルツハイマー治療薬のグローバル市場(2014-2018)...市場調査レポートについてご紹介

【英文タイトル】Global Alzheimer's Drugs Market 2014-2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
06.1 Dementia
06.2 Epidemiology & Forecast (2013-2018)
06.3 Types of Dementia
07. Alzheimer’s Disease
07.1 A Global Burden
07.2 Etiology
07.3 Cost of Care
07.4 Alzheimer’s Disease & Caregiving
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by MOA
09.1.1 AChE Inhibitors
09.1.2 Glutamate Inhibitors
10. Market Assessment of Top Drugs
10.1 Aricept
10.1.1 Sales
10.1.2 Key Regulatory Approvals and Agreements
10.1.3 US Spending by Various Channels 2010-2013
10.2 Exelon
10.2.1 Sales
10.2.2 Key Regulatory Approvals and Agreements
10.2.3 US Spending by Various Channels 2010-2013
10.3 Namenda
10.3.1 Sales
10.3.2 Key Regulatory Approvals and Agreements
10.3.3 US Spending by Various Channels 2010-2013
10.4 Radazyne
10.4.1 Sales
10.4.2 Key Regulatory Approvals and Agreements
11. Competitive Assessment of Top Drugs
12. Focus on Alzheimer’s Research
12.1 National Alzheimer’s Project Act
12.2 Clinical Pipeline
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.2 Market Share Analysis 2013
22. Future Vendors Expected To Tap the Market
23. Key Vendor Analysis
23.1 Eisai Co., Ltd.
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Sales by Geography
23.1.4 Revenue Comparison
23.1.5 Sales by Geography
23.1.6 Business Strategy
23.1.7 Key Information
23.1.8 SWOT Analysis
23.1.9 Strengths
23.1.10 Weaknesses
23.1.11 Opportunities
23.1.12 Threats
23.2 Forest Laboratories Inc.
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business/Product Segmentation
23.2.4 Product Segmentation by Revenue 2013
23.2.5 Business/Products Segmentation by Revenue 2012 and 2013
23.2.6 Sales by Geography
23.2.7 Business Strategy
23.2.8 Key Information
23.2.9 SWOT Analysis
23.2.10 Strengths
23.2.11 Weaknesses
23.2.12 Opportunities
23.2.13 Threats
23.3 Janssen Pharmaceuticals Inc.
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Product Segmentation
23.3.4 Business Strategy
23.3.5 Key Information
23.3.6 SWOT Analysis
23.3.7 Strengths
23.3.8 Weaknesses
23.3.9 Opportunities
23.3.10 Threats
23.4 Novartis AG
23.4.1 Key Facts
23.4.2 Business Description
23.4.3 Business Segmentation
23.4.4 Revenue by Business Segmentation
23.4.5 Revenue Comparison 2012 and 2013
23.4.6 Sales by Geography
23.4.7 Business Strategy
23.4.8 Key Developments
23.4.9 SWOT Analysis
23.4.10 Strengths
23.4.11 Weaknesses
23.4.12 Opportunities
23.4.13 Threats
24. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Projected Prevalence of Dementia by Regions 2013-2050 (in millions)
Exhibit 3: Projected Prevalence of Dementia by Regions 2013-2018 (in millions)
Exhibit 4: Types of Dementia by Prevalence 2013
Exhibit 5: Alzheimer’s Disease and Other Dementias Burden by Geographical Segmentation (Annually) 2013
Exhibit 6: Costs of Care by Payer for Americans Age 65 and Older with Alzheimer‘s Disease and Other Dementias 2013
Exhibit 7: Distribution of Alzheimer’s Caregivers by Age, 2013
Exhibit 8: Projected Prevalence of dependence in 2030 (in percent)
Exhibit 9: Global Alzheimer’s Disease Drugs Market 2013-2018 (US$ billion)
Exhibit 10: Global Alzheimer’s Drugs Market Segmentation by MOA
Exhibit 11: Eisai Co. Ltd.’s Aricept Revenue FY1996-FY2013 (US$ million)
Exhibit 12: Eisai Co. Ltd.’s Aricept Geography-wise Revenue FY1996-FY2010 (US$ million)
Exhibit 13: Eisai Co. Ltd.’s Aricept Geography-wise Revenue FY2011-FY2013 (US$ million)
Exhibit 14: Key Event Timeline of Aricept Formulations
Exhibit 15: Timeline for Aricept Formulations in US and Europe
Exhibit 16: US Spending on Aricept by Various Channels 2010-2013
Exhibit 17: Novartis AG’s Exelon Revenue 2001-2013 (US$ million)
Exhibit 18: Novartis AG’s Exelon Geography-Wise Revenue 2001-2013 (US$ million)
Exhibit 19: Key Event Timeline of Exelon Formulations
Exhibit 20: US Spending on Exelon by Various Channels 2010-2013
Exhibit 21: Forest’s Namenda Revenue 2004-2014 (FY ending March 2014) (US$ million)
Exhibit 22: Key Event Timeline of Namenda Formulations
Exhibit 23: US Spending on Namenda by Various Channels 2010-2013
Exhibit 24: Razadyne Revenue 2007-2009 (US$ million)
Exhibit 25: Key Event Timeline of Razadyne
Exhibit 26: Sales of Top 3 Alzheimer’s Drugs FY 2004-2013 (US$ million)
Exhibit 27: Sales of Top 3 Alzheimer’s Drugs 2004-2013 (US$ million)
Exhibit 28: Alzheimer’s Disease Research Projects by NIH Institutes and Centers 2011
Exhibit 29: NIH funded Alzheimer’s Disease Research Projects by CADRO topic 2011
Exhibit 30: Classification of Disease Modifying Pipeline Molecules by MOA
Exhibit 31: Clinical Trials of Alzheimer’s Disease by Phase 2013
Exhibit 32: Clinical Trials of Alzheimer’s Disease by Recruitment Status 2013
Exhibit 33: Promising Late Stage Pipeline Molecules 2013
Exhibit 34: Global Alzheimer’s Drugs market by Geographical Segmentation 2013
Exhibit 35: 65+ Global Population 2014-2018 (in million)
Exhibit 36: Global Alzheimer’s Drugs Market Share Analysis 2013
Exhibit 37: Eisai Co., Ltd.: Geographical Segmentation of Revenue for 2013 and 2012(US$ billion)
Exhibit 38: Eisai Co., Ltd.: Revenue comparison for the last 3 years (US$ billion)
Exhibit 39: Eisai Co., Ltd.: Sales by Geography for 2013 (US$ billion)
Exhibit 40: Forest Laboratories Inc.: Product Segmentation (by therapeutic areas) 2013
Exhibit 41: Forest Laboratories Inc.: Product Segmentation by Revenue 2013
Exhibit 42: Forest Laboratories Inc.: Product Segmentation by Revenue 2012 and 2013(US$ million)
Exhibit 43: Company Name: Sales by Geography 2013
Exhibit 44: Janssen Pharmaceuticals, Inc.: Product Segmentation 2013
Exhibit 45: Novartis AG: Business Segmentation
Exhibit 46: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 47: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 48: Novartis AG: Revenue by Geographical Segmentation 2013


【レポート販売概要】

■ タイトル:アルツハイマー治療薬のグローバル市場(2014-2018)
■ 英文:Global Alzheimer's Drugs Market 2014-2018
■ 発行日:2014年6月20日
■ 調査会社:Technavio
■ 商品コード:IRTNTR3675
■ 調査対象地域:グローバル
  • 通信用電力システムの世界市場2016-2020
    About Power Systems Power systems are used in all telecommunication installations for controlling, monitoring, and measuring the flow of power across telecom networks. These systems are made up of a combination of smaller systems such as converters, distributors, controllers, and backup systems that bear different technical specifications. The primary application of telecom power systems is in wir …
  • SEX関連用品の世界市場2015-2019
    About Sexual Wellness Sexual wellness is a term used to describe the enhancement of sexual health and experience. Sexual wellness products include condoms, sensual lingerie, pleasure-enhancing devices, lubricants, toys, contraceptives, costumes, accessories, adult games, oils, and herbal supplements. These products are used for sexual wellbeing, to enhance pleasure, and to induce an element of adv …
  • 逆浸透膜(RO膜)の世界市場:材料、需要先、用途、地域別分析
    The reverse osmosis membrane (RO) market, in terms of value, is projected to reach USD 5.00 Billion by 2021, at a CAGR of 15.75%, between 2016 and 2021. High-growth application areas such as sea water desalination systems and RO purification systems and stringent regulations due to increased concerns over safe drinking water are the key factors driving the growth of the RO market. The cellulose-ba …
  • トリエチレングリコール(TEG)の世界市場分析:用途別(天然ガス脱水、溶剤、可塑剤、ポリウレタン、保湿剤、ポリエステル樹脂)、セグメント予測
    Global Triethylene Glycol (TEG) Market is expected to reach USD 718.3 million by 2022, according to a new study by Grand View Research, Inc. Increasing natural gas output is expected to be one of the key factors driving TEG demand over the forecast period. Rise in gas production is expected to have a two-fold impact on the TEG market providing abundant feedstock for TEG manufacture on the supply s …
  • 世界のアパレル市場:ビジネス状況アップデート(2014年4Q)
    This report provides information, analysis and valuable insight on developments relating to the global apparel industry in the following categories: corporate social responsibility (CSR); financial results; joint ventures, cooperation, licensing and distribution; manufacturing facilities; new stores; online retailing; and store closures. Companies, other organisations, individuals and brands featu …
  • パワーマネジメントIC(電源IC)の世界市場2016-2020
    About Global Power Management IC Market The global power management IC market is driven by factors such as increasing demand for energy-efficient devices. A dramatic rise in the consumption and cost of energy worldwide has forced consumers to save energy and devise methods to minimize environmental impacts caused by carbon emissions. This has increased the demand for power-saving electronic produc …
  • インドの医薬品市場:ジェネリック医薬品、OTC医薬品、特許薬、バイオシミラー
    What can be expected from the Indian Pharmaceutical market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there. Our 194-page report provides 117 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you a …
  • 北米の道路貨物輸送の世界市場2017-2021
    About Rail Freight TransportationRail freight transportation is used for the movement of heavy goods such as coal, metals, and oils. Often, rail freight service providers go beyond logistics and provide value-added services such as loading and unloading, documentation services, and packaging. They also provide strategic and operational services to many shippers worldwide. Freight service providers …
  • OMV Aktiengesellschaft:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    OMV Aktiengesellschaft Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary OMV Aktiengesellschaft Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
  • アカウンタブルケアソリューションの世界市場予測
    The global accountable care solutions market is projected to reach USD 18.86 Billion by 2021, at a CAGR of 16.6% from 2016 to 2021. The market growth can be attributed to a number of factors such as increasing government initiatives, implementation of initiatives to shift the burden of financial risk from payers to healthcare providers, growing need to curb healthcare costs and advancing IT and bi …
  • ジメチルエーテル(DME)の世界市場動向及び予測
    Dimethyl ether (DME) is an non-poisonous gas, which is liquefiable at a pressure of around 6 bars for storage purpose. It is used as a solvent in the petrochemical industry. The raw materials used in DME manufacturing process are coal, natural gas, bio-based feedstock and methanol. DME consist no sulfur content which gives an advantage of clean burning properties. It has various applications such …
  • 世界のFeminine Hygiene市場におけるニュース・イベント動向(2014年2月)
    Synopsis The report provides a review of the latest news and key events in the global feminine hygiene market during February 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global feminine hygiene market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest event …
  • 血管炎(Vasculitis):世界の治験レビュー(2015年上半期版)
    Vasculitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Vasculitis Global Clinical Trials Review, H1, 2015" provides data on the Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
  • 精密林業の世界市場予測(~2024年)
    Precision forestry market anticipated to grow at CAGR of 9.0% from 2019 to 2024 The precision forestry market was worth USD 3.9 billion in 2019 and is projected to reach USD 6.1 billion by 2024, at a CAGR of 9.0% during 2019–2024. The major factors driving the growth of the precision forestry market are increasing mechanization in emerging countries of Asia Pacific & Africa, rising construction ac …
  • AEC(建築、エンジニアリング、建設)ソフトウェアのグローバル市場(2014-2018)
    About AEC AEC software facilitates in the designing of large and complex industrial plants, multi-industry international exposition centers, and other types of complex building or structure. It improves the efficiency of construction and engineering processes by providing two-dimensional as well as three-dimensional simulation models to end-users for analysis. Thus, the use of AEC software helps i …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。